Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

112.00
Delayed Data
As of 4:00pm ET
 -6.50 / -5.49%
Today’s Change
36.62
Today|||52-Week Range
123.75
+81.52%
Year-to-Date
Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger
Jun 22 / Zacks.com - Paid Partner Content
Small Cancer Biotech Space in Focus, 3 Stocks Up 100% & More
Jun 21 / Zacks.com - Paid Partner Content
Pharma recovers composure as price concerns ease
Jun 21 / FT.com - Paid Partner Content
 

Today’s Trading

Previous close118.50
Today’s open110.35
Day’s range104.90 - 113.30
Volume3,073,640
Average volume (3 months)877,491
Market cap$4.9B
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-46.99%
Earnings growth (this year)+3.54%
Earnings growth (next 5 years)-23.92%
Revenue growth (last year)-56.28%
P/E ratioNM
Price/Sales373.75
Price/Book5.55

Competitors

 Today’s
change
Today’s
% change
KITEKite Pharma Inc+6.67+7.10%
TECHBio-Techne Corp+1.20+1.03%
NBIXNeurocrine Bioscienc...+0.23+0.49%
EXASExact Sciences Corp+0.80+2.30%
Data as of 4:14pm ET, 06/23/2017

Financials

Next reporting dateAugust 16, 2017
EPS forecast (this quarter)-$1.68
Annual revenue (last year)$6.2M
Annual profit (last year)-$263.5M
Net profit margin-4,281.19%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Nick Leschly
Chief Operating Officer
Susanna G. High
Corporate headquarters
Cambridge, Massachusetts

Forecasts